Biotech

All Articles

Former Seagen CEO reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer last year for a monst...

Ironwood creates more purpose $1B GI medicine along with new subgroup information

.On the heels of a period 3 win that stopped working to blow away real estate investors, Ironwood Ph...

Novartis inks $150M offer for autoimmune molecular glue

.Do not cease Monte Rosa Rehabs right now. The Boston-based biotech is having a ball after signing a...

Jade takes director group along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings as...

Septerna goes public with upsized offering of $288M

.Celebrating his company's upsized initial public offering (IPO), Septerna chief executive officer J...

AbbVie brings in Richter richer, paying $25M to create finding pact

.AbbVie has actually gone back to the source of its own antipsychotic giant Vraylar trying to find a...

GenSight gets in final weeks of money path as profits stream noses out of scope

.GenSight Biologics is weeks off of losing money. Again. The biotech only has sufficient cash money ...

AZ licenses discarded rare condition medication to Monopar Therapeutics

.Monopar Rehabs is actually recuperating a medication from the scrap heap of AstraZeneca's unusual a...

Arcus' brand-new HIF-2a data in kidney cancer cells mean potential edge over Merck's Welireg, analysts point out

.Along with new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of prof...

Roche wagers as much as $1B to grow Dyno gene treatment delivery contract

.After forming a gene therapy relationship with Dyno Therapeutics in 2020, Roche is actually back fo...